|
|
Volumn 173, Issue JULY SUPPL. 34, 1998, Pages 55-63
|
|
Abecarnil, a new beta-carboline, in the treatment of anxiety disorders
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABECARNIL;
BENZODIAZEPINE DERIVATIVE;
BETA CARBOLINE DERIVATIVE;
DIAZEPAM;
LORAZEPAM;
OXAZEPAM;
PLACEBO;
ANXIOLYTIC AGENT;
CARBOLINE DERIVATIVE;
ABDOMINAL DISCOMFORT;
ADULT;
ANXIETY NEUROSIS;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DROWSINESS;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
FATIGUE;
FEMALE;
HUMAN;
INSOMNIA;
MAJOR CLINICAL STUDY;
MALE;
NAUSEA;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
VERTIGO;
ANXIETY DISORDER;
DOUBLE BLIND PROCEDURE;
MIDDLE AGED;
MULTICENTER STUDY;
TREATMENT OUTCOME;
WITHDRAWAL SYNDROME;
ADULT;
ANTI-ANXIETY AGENTS;
ANXIETY DISORDERS;
CARBOLINES;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
SUBSTANCE WITHDRAWAL SYNDROME;
TREATMENT OUTCOME;
|
|
EID: 0031987102
PISSN: 00071250
EISSN: None
Source Type: Journal
DOI: 10.1192/s0007125000293537 Document Type: Article |
|
Times cited : (28)
|
|
References (35)
|
